CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.72
−0.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 15.78x
- P/E 2027E
- 128.33x
- P/E 2028E
- 17.40x
- P/S forward
- 2.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.20x
- PEG TTM
- —
- Price / book
- 1.31x
- Price / sales
- 1.30x
- Price / cash flow
- 2.37x
Enterprise value
- Enterprise value
- $490.2M
- EV / sales
- 1.06x
- EV / EBITDA
- 1.96x
- EV / EBIT
- 2.26x
- Market cap
- $601.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026